European Equities Traded in the US as ADRs Little Changed in Monday Trading

European equities traded in the US as American depositary receipts were little changed late Monday morning, easing less than 0.1% to 1,630.2 on the S&P Europe Select ADR Index.

From continental Europe, the risers were led by biotech firm Evaxion (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which gained 5.2% and 4.5% respectively. They were followed by 3D printer company Materialise (MTLS) and biotech firm BioNTech (BNTX), which were up 2.2% and 1.7% respectively.

The decliners from continental Europe were led by consumer goods giant Unilever (UL) and medical device maker EDAP TMS (EDAP), which fell 7.3% and 3.4% respectively. They were followed by pharmaceutical companies Novo Nordisk (NVO) and Sanofi (SNY), which were down 2.9% and 2.1% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Autolus Therapeutics (AUTL), which advanced 37% and 3.5% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Akari Therapeutics (AKTX), which increased 3.1% and 2.8% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Amarin (AMRN) and pharmaceutical company Silence Therapeutics (SLN), which dropped 6.2% and 2.2% respectively. They were followed by alcoholic beverage company Diageo (DEO) and mining company BHP Group (BHP), which were off 1.8% and 0.5% respectively.